Concepedia

Author

J Bourret

Pfizer (United States)

Also Known As

J A Bourret, J BOURRET, J Bourret, J. Bourret, Jeffrey A Bourret, Jeffrey A. Bourret, Jeffrey Bourret

100

Publications

904

Citations

11

H-Index

26

Concepts

All Affiliations

Pfizer (United States)University of YorkUniversité Claude Bernard Lyon 1
JB

About

J Bourret is an author at Pfizer (United States) specializing in medicine, spinal cord injury, and orthopaedics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

542

2

Orthopaedics

2

2

70

3

Public Health

1

1

34

4

Health Policy

1

1

34

5

Neurology

1

1

29

J Bourret

×

11

Publications

804

Citations

11

H-Index

YearCitations

Quantitative histological data on disuse osteoporosis

P Minaire, Pierre J. Meunier, C Edouard,

Calcified Tissue International

1974

438

The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives.

Steven R. Feldman, Bernard S. Goffe, Gary Rice,

PubMed

2016

110

Histological and hormonal testicular changes in spinal cord patients

A Leriche, Émilie Bérard, J L Vauzelle,

Spinal Cord

1977

41

Real-world evaluation of TNF-inhibitor utilization in rheumatoid arthritis

James Harnett, Daniel Wiederkehr, Robert A. Gerber,

Journal of Medical Economics

2015

36

Primary Nonadherence, Associated Clinical Outcomes, and Health Care Resource Use Among Patients with Rheumatoid Arthritis Prescribed Treatment with Injectable Biologic Disease-Modifying Antirheumatic Drugs

James Harnett, Daniel Wiederkehr, Robert A. Gerber,

Journal of Managed Care & Specialty Pharmacy

2016

36

Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population

J Bourret, PharmD, Bcps,

2014

34

Life expectancy following spinal cord injury: a ten-years survey in the Rhône-Alpes region, France, 1969-1980

P Minaire, P Demolin, J Bourret,

Spinal Cord

1983

29

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis: Modeling the Cost of Treatment Strategies in the United States

Lindsay Claxton, Michelle Jenks, Matthew Taylor,

Journal of Managed Care & Specialty Pharmacy

2016

27

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis After Methotrexate or After 1 or 2 TNF Inhibitors from a U.S. Payer Perspective

Lindsay Claxton, Matthew Taylor, Arif Soonasra,

Journal of Managed Care & Specialty Pharmacy

2018

24

An economic evaluation of tofacitinib for the treatment of moderately-to-severely active ulcerative colitis: modeling the cost of treatment strategies in the United States

Sandra Milev, Marco DiBonaventura, Peter Quon,

Journal of Medical Economics

2019

17

Page 1